Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge represents Cinven in connection with the acquisition of Säkra
Mandate

Vinge represents Cinven in connection with the acquisition of Säkra

September 06, 2022 Employment and Benefits Banking and Finance M&A Intellectual Property IT, Telecommunications and Outsourcing Commercial Agreements EU, Competition and Regulatory Insurance Law

Vinge has represented the international private equity firm Cinven in connection with its acquisition of the Säkra group (“Säkra”).

Säkra, with about 350 insurance professionals across 60 offices throughout Sweden, provides tailor-made insurance solutions, occupational pension plans and advisory services, and is one of the leading insurance intermediaries in Sweden. The acquisition of Säkra marks the fourth investment from Cinven’s inaugural Strategic Financials Fund (‘SFF’).

The SFF builds on Cinven’s leading financial services investment platform in Europe with an investment strategy focused on areas where Cinven has developed significant investment expertise, such as life and non-life insurance and reinsurance, asset-backed speciality finance, wealth management, insurance distributors and other ‘capital light’ tech-enabled financial service providers.

The acquisition is subject to approvals from the Swedish Financial Supervisory Authority and the Swedish Competition Authority.

Vinge's team consisted mainly of Christina Kokko, Samra Baytar, Carl Fredrik Wachtmeister and Robin Fagerström (M&A), Viveka Classon and Fabian Ekeblad (Corporate Insurance), Emma Stuart-Beck, Caroline Krassén, Henrik Schön and David Flodin (Financial Services), Hedvig Ekdahl (Commercial Agreements), Kristoffer Larsson (Real Estate), Louise Brorsson Salomon, Kamyar Najmi and Ellen Flygt (Banking and Finance), Rebecka Målquist (IP), Nicklas Thorgerzon (IT and GDPR) Sara Strandberg (Employment), David Olander and Victoria Fredén (ECR), and Emy Rydén (project assistant).

 

Related

Vinge has advised Vitamin Well and its majority shareholders Cinven, Bridgepoint and the founders on Vitamin Well's combination with EMPWR

 Vinge has advised Vitamin Well and its majority shareholders Cinven, the founders of Vitamin Well and Bridgepoint on Vitamin Well's acquisition of EMPWR Nutrition Group from majority seller Waterland Private Equity Investments.
July 03, 2026

Vinge has advised Morrow Bank in connection with its issuances of primary capital instruments (AT1) and tier 2 capital bonds (T2)

 The issuances comprised perpetual AT1 bonds of NOK 300 million with a floating coupon of 3-month NIBOR + 425 basis points and a first call date in 2031, as well as subordinated Tier 2 bonds of SEK 200 million with a floating coupon of 3-month STIBOR + 325 basis points and a first call date in 2031. The bonds are intended to be admitted to trading on Nasdaq Stockholm.
July 03, 2026

Vinge advises Wihlborgs Fastigheter in connection with the financing of property acquisition valued at SEK 13.3 billion

 Vinge advises Wihlborgs Fastigheter AB (publ) in connection with the financing of the acquisition of all of Castellum’s property holdings in Malmö, Lund and Helsingborg. The financing has been secured through Danske Bank, SEB and Swedbank.
June 29, 2026